Role of ErbB4 in breast cancer

M. Sundvall, Kristiina Iljin, Sami Kilpinen, Henri Sara, Olli Kallioniemi, K. Elenius (Corresponding Author)

Research output: Contribution to journalArticleScientificpeer-review

77 Citations (Scopus)

Abstract

Members of the ErbB subfamily of receptor tyrosine kinases are important regulators of normal mammary gland physiology, and aberrations in their signaling have been associated with breast tumorigenesis. Therapeutics targeting epidermal growth factor receptor (EGFR = ErbB1) or ErbB2 in breast cancer have been approved for clinical use. In contrast, relatively little is known about the biological significance of ErbB4 signaling in breast cancer. This review focuses on recent advances in our understanding about the role of ErbB4 in breast carcinogenesis, as well as in the potential clinical relevance of ErbB4 in breast cancer prognostics and therapy.
Original languageEnglish
Pages (from-to)259 - 268
Number of pages10
JournalJournal of Mammary Gland Biology and Neoplasia
Volume13
Issue number2
DOIs
Publication statusPublished - 2008
MoE publication typeA1 Journal article-refereed

Fingerprint

Breast Neoplasms
Carcinogenesis
Breast
Human Mammary Glands
Epidermal Growth Factor Receptor
Protein-Tyrosine Kinases
Therapeutics
ErbB Receptors

Keywords

  • Alternative splicing
  • Epidermal growth factor
  • Estrogen receptor
  • HER4
  • Neuregulins
  • Targeted therapeutics

Cite this

Sundvall, M., Iljin, K., Kilpinen, S., Sara, H., Kallioniemi, O., & Elenius, K. (2008). Role of ErbB4 in breast cancer. Journal of Mammary Gland Biology and Neoplasia, 13(2), 259 - 268. https://doi.org/10.1007/s10911-008-9079-3
Sundvall, M. ; Iljin, Kristiina ; Kilpinen, Sami ; Sara, Henri ; Kallioniemi, Olli ; Elenius, K. / Role of ErbB4 in breast cancer. In: Journal of Mammary Gland Biology and Neoplasia. 2008 ; Vol. 13, No. 2. pp. 259 - 268.
@article{5394334f01004d43b5d84cd3d419d13b,
title = "Role of ErbB4 in breast cancer",
abstract = "Members of the ErbB subfamily of receptor tyrosine kinases are important regulators of normal mammary gland physiology, and aberrations in their signaling have been associated with breast tumorigenesis. Therapeutics targeting epidermal growth factor receptor (EGFR = ErbB1) or ErbB2 in breast cancer have been approved for clinical use. In contrast, relatively little is known about the biological significance of ErbB4 signaling in breast cancer. This review focuses on recent advances in our understanding about the role of ErbB4 in breast carcinogenesis, as well as in the potential clinical relevance of ErbB4 in breast cancer prognostics and therapy.",
keywords = "Alternative splicing, Epidermal growth factor, Estrogen receptor, HER4, Neuregulins, Targeted therapeutics",
author = "M. Sundvall and Kristiina Iljin and Sami Kilpinen and Henri Sara and Olli Kallioniemi and K. Elenius",
year = "2008",
doi = "10.1007/s10911-008-9079-3",
language = "English",
volume = "13",
pages = "259 -- 268",
journal = "Journal of Mammary Gland Biology and Neoplasia",
issn = "1083-3021",
publisher = "Springer",
number = "2",

}

Sundvall, M, Iljin, K, Kilpinen, S, Sara, H, Kallioniemi, O & Elenius, K 2008, 'Role of ErbB4 in breast cancer', Journal of Mammary Gland Biology and Neoplasia, vol. 13, no. 2, pp. 259 - 268. https://doi.org/10.1007/s10911-008-9079-3

Role of ErbB4 in breast cancer. / Sundvall, M.; Iljin, Kristiina; Kilpinen, Sami; Sara, Henri; Kallioniemi, Olli; Elenius, K. (Corresponding Author).

In: Journal of Mammary Gland Biology and Neoplasia, Vol. 13, No. 2, 2008, p. 259 - 268.

Research output: Contribution to journalArticleScientificpeer-review

TY - JOUR

T1 - Role of ErbB4 in breast cancer

AU - Sundvall, M.

AU - Iljin, Kristiina

AU - Kilpinen, Sami

AU - Sara, Henri

AU - Kallioniemi, Olli

AU - Elenius, K.

PY - 2008

Y1 - 2008

N2 - Members of the ErbB subfamily of receptor tyrosine kinases are important regulators of normal mammary gland physiology, and aberrations in their signaling have been associated with breast tumorigenesis. Therapeutics targeting epidermal growth factor receptor (EGFR = ErbB1) or ErbB2 in breast cancer have been approved for clinical use. In contrast, relatively little is known about the biological significance of ErbB4 signaling in breast cancer. This review focuses on recent advances in our understanding about the role of ErbB4 in breast carcinogenesis, as well as in the potential clinical relevance of ErbB4 in breast cancer prognostics and therapy.

AB - Members of the ErbB subfamily of receptor tyrosine kinases are important regulators of normal mammary gland physiology, and aberrations in their signaling have been associated with breast tumorigenesis. Therapeutics targeting epidermal growth factor receptor (EGFR = ErbB1) or ErbB2 in breast cancer have been approved for clinical use. In contrast, relatively little is known about the biological significance of ErbB4 signaling in breast cancer. This review focuses on recent advances in our understanding about the role of ErbB4 in breast carcinogenesis, as well as in the potential clinical relevance of ErbB4 in breast cancer prognostics and therapy.

KW - Alternative splicing

KW - Epidermal growth factor

KW - Estrogen receptor

KW - HER4

KW - Neuregulins

KW - Targeted therapeutics

U2 - 10.1007/s10911-008-9079-3

DO - 10.1007/s10911-008-9079-3

M3 - Article

VL - 13

SP - 259

EP - 268

JO - Journal of Mammary Gland Biology and Neoplasia

JF - Journal of Mammary Gland Biology and Neoplasia

SN - 1083-3021

IS - 2

ER -

Sundvall M, Iljin K, Kilpinen S, Sara H, Kallioniemi O, Elenius K. Role of ErbB4 in breast cancer. Journal of Mammary Gland Biology and Neoplasia. 2008;13(2):259 - 268. https://doi.org/10.1007/s10911-008-9079-3